These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The redox chemistry of the Alzheimer's disease amyloid beta peptide. Smith DG; Cappai R; Barnham KJ Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250 [TBL] [Abstract][Full Text] [Related]
9. Regulatory Activities of Dopamine and Its Derivatives toward Metal-Free and Metal-Induced Amyloid-β Aggregation, Oxidative Stress, and Inflammation in Alzheimer's Disease. Nam E; Derrick JS; Lee S; Kang J; Han J; Lee SJC; Chung SW; Lim MH ACS Chem Neurosci; 2018 Nov; 9(11):2655-2666. PubMed ID: 29782798 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and evaluation of multitarget-directed selenium-containing clioquinol derivatives for the treatment of Alzheimer's disease. Wang Z; Wang Y; Li W; Mao F; Sun Y; Huang L; Li X ACS Chem Neurosci; 2014 Oct; 5(10):952-62. PubMed ID: 25121395 [TBL] [Abstract][Full Text] [Related]
11. Importance of the Dimethylamino Functionality on a Multifunctional Framework for Regulating Metals, Amyloid-β, and Oxidative Stress in Alzheimer's Disease. Derrick JS; Kerr RA; Korshavn KJ; McLane MJ; Kang J; Nam E; Ramamoorthy A; Ruotolo BT; Lim MH Inorg Chem; 2016 May; 55(10):5000-13. PubMed ID: 27119456 [TBL] [Abstract][Full Text] [Related]
13. New multi-target-directed small molecules against Alzheimer's disease: a combination of resveratrol and clioquinol. Mao F; Yan J; Li J; Jia X; Miao H; Sun Y; Huang L; Li X Org Biomol Chem; 2014 Aug; 12(31):5936-44. PubMed ID: 24986600 [TBL] [Abstract][Full Text] [Related]
14. RTHLVFFARK-NH Meng J; Zhang H; Dong X; Liu F; Sun Y J Inorg Biochem; 2018 Apr; 181():56-64. PubMed ID: 29407908 [TBL] [Abstract][Full Text] [Related]
15. Effect of metal chelators on the aggregation of beta-amyloid peptides in the presence of copper and iron. Tahmasebinia F; Emadi S Biometals; 2017 Apr; 30(2):285-293. PubMed ID: 28281098 [TBL] [Abstract][Full Text] [Related]
16. Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Huang X; Moir RD; Tanzi RE; Bush AI; Rogers JT Ann N Y Acad Sci; 2004 Mar; 1012():153-63. PubMed ID: 15105262 [TBL] [Abstract][Full Text] [Related]
18. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease. Savelieff MG; DeToma AS; Derrick JS; Lim MH Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056 [TBL] [Abstract][Full Text] [Related]
19. A cAMP analog attenuates beta-amyloid (1-42)-induced mitochondrial dysfunction and spatial learning and memory deficits. Aghsami M; Sharifzadeh M; Sepand MR; Yazdankhah M; Seyednejad SA; Pourahmad J Brain Res Bull; 2018 Jun; 140():34-42. PubMed ID: 29605485 [TBL] [Abstract][Full Text] [Related]
20. N,N'-1,10-Bis(Naringin) Triethylenetetraamine, Synthesis and as a Cu(II) Chelator for Alzheimer's Disease Therapy. Guo LX; Sun B Biol Pharm Bull; 2021 Jan; 44(1):51-56. PubMed ID: 33162492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]